| 1 | Risk of Major Adverse Cardiovascular Events After SARS-CoV-2 Infection in British Columbia: A Population-Based Study | 2.3 | 3 | Citations (PDF) |
| 2 | Hepatitis C Attributable Healthcare Costs and Mortality among Immigrants: A Population-Based Matched Cohort Study | 2.0 | 1 | Citations (PDF) |
| 3 | Performance of <scp>HCV</scp> core antigen and <scp>PCR</scp> testing in a predominantly genotype 3 population | 2.1 | 2 | Citations (PDF) |
| 4 | Impact of the COVID-19 Pandemic on Hepatitis C Treatment Initiation in British Columbia, Canada: An Interrupted Time Series Study | 3.3 | 3 | Citations (PDF) |
| 5 | Bridging Hepatitis C Care Gaps: A Modeling Approach for Achieving the WHO’s Targets in Ontario, Canada | 3.3 | 0 | Citations (PDF) |
| 6 | Clinical severity of Omicron subvariants BA.1, BA.2, and BA.5 in a population‐based cohort study in British Columbia, Canada | 3.8 | 21 | Citations (PDF) |
| 7 | A population-based assessment of myocarditis after messenger RNA COVID-19 booster vaccination among adult recipients | 2.2 | 4 | Citations (PDF) |
| 8 | The Cascade of Care for Hepatitis C Treatment in Rwanda: A Retrospective Cohort Study of the 2017–2019 Mass Screening and Treatment Campaign | 3.3 | 14 | Citations (PDF) |
| 9 | A population‐based study of reported hepatitis C diagnoses from 1998 to 2018 in immigrants and nonimmigrants in Quebec, Canada | 2.1 | 6 | Citations (PDF) |
| 10 | Engagement with the HCV care cascade among high-risk groups: A population-based study | 4.6 | 10 | Citations (PDF) |
| 11 | Declining incidence of hepatitis C related hepatocellular carcinoma in the era of interferon‐free therapies: A population‐based cohort study | 4.1 | 12 | Citations (PDF) |
| 12 | British Columbia’s Index of Multiple Deprivation for Community Health Service Areas | 1.7 | 14 | Citations (PDF) |
| 13 | Tracking Public Attitudes Toward COVID-19 Vaccination on Tweets in Canada: Using Aspect-Based Sentiment Analysis | 4.9 | 31 | Citations (PDF) |
| 14 | Mathematical modeling of COVID-19 in British Columbia: An age-structured model with time-dependent contact rates | 2.3 | 24 | Citations (PDF) |
| 15 | Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study | 23.6 | 510 | Citations (PDF) |
| 16 | HBV elimination in sub-Saharan Africa: Rwanda's approach to health system integration | 23.6 | 8 | Citations (PDF) |
| 17 | Impact of COVID‐19 pandemic on HCV care cascade in Rwanda: Ecological study from July 2019 to June 2021 | 1.5 | 0 | Citations (PDF) |
| 18 | Cohort profile: the British Columbia COVID-19 Population Mixing Patterns Survey (BC-Mix) | 2.0 | 8 | Citations (PDF) |
| 19 | Impact of Hepatitis B Virus Infection, Non-alcoholic Fatty Liver Disease, and Hepatitis C Virus Co-infection on Liver-Related Death among People Tested for Hepatitis B Virus in British Columbia: Results from a Large Longitudinal Population-Based Cohort Study | 3.3 | 8 | Citations (PDF) |
| 20 | Association between markers of immune response at hospital admission and COVID‐19 disease severity and mortality: A meta‐analysis and meta‐regression | 3.8 | 48 | Citations (PDF) |
| 21 | The case for simplifying and using absolute targets for viral hepatitis elimination goals | 2.1 | 34 | Citations (PDF) |
| 22 | Tracking COVID-19 Discourse on Twitter in North America: Infodemiology Study Using Topic Modeling and Aspect-Based Sentiment Analysis | 4.9 | 140 | Citations (PDF) |
| 23 | Cohort profile: development and characteristics of a retrospective cohort of individuals dispensed prescription opioids for non-cancer pain in British Columbia, Canada | 2.0 | 6 | Citations (PDF) |
| 24 | Differences in risk factors for hepatitis B, hepatitis C, and human immunodeficiency virus infection by ethnicity: A large population-based cohort study in British Columbia, Canada | 2.2 | 8 | Citations (PDF) |
| 25 | Impact of direct-acting antivirals for HCV on mortality in a large population-based cohort study | 3.6 | 54 | Citations (PDF) |
| 26 | Impact of HCV infection and ethnicity on incident type 2 diabetes: findings from a large population-based cohort in British Columbia | 3.7 | 16 | Citations (PDF) |
| 27 | Mental Health and Substance Use Associated with Hospitalization among People with COVID-19: A Population-Based Cohort Study | 3.3 | 19 | Citations (PDF) |
| 28 | Prevalence of Injecting Drug Use and Coverage of Interventions to Prevent HIV and Hepatitis C Virus Infection Among People Who Inject Drugs in Canada | 2.9 | 65 | Citations (PDF) |
| 29 | Loss to follow‐up: A significant barrier in the treatment cascade with direct‐acting therapies | 2.1 | 30 | Citations (PDF) |
| 30 | Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis | 3.6 | 154 | Citations (PDF) |
| 31 | Role of unsafe medical practices and sexual behaviours in the hepatitis B and C syndemic and HIV co-infection in Rwanda: a cross-sectional study | 2.0 | 9 | Citations (PDF) |
| 32 | Estimating chronic hepatitis C prevalence in British Columbia and Ontario, Canada, using population‐based cohort studies | 2.1 | 13 | Citations (PDF) |
| 33 | Real-world effectiveness of sofosbuvir/velpatasvir/voxilaprevir as a hepatitis C virus infection salvage treatment | 3.6 | 4 | Citations (PDF) |
| 34 | Classifying people living with hepatitis C virus using a population-level latent class analysis to inform optimal integration of health services | 3.6 | 0 | Citations (PDF) |
| 35 | Opportunities to enhance linkage to hepatitis C care among people hospitalised for injection drug use-related complications: a population-based study | 3.6 | 3 | Citations (PDF) |
| 36 | Frequency of prenatal hepatitis C screening and diagnosis in British Columbia, 2008–2018 | 3.6 | 0 | Citations (PDF) |
| 37 | All-cause mortality and liver-related death following entecavir, tenofovir disoproxil fumarate or lamivudine therapy among treatment-naive chronic hepatitis B patients in British Columbia, Canada | 3.6 | 0 | Citations (PDF) |
| 38 | The impact of SVR from direct‐acting antiviral‐ and interferon‐based treatments for HCV on hepatocellular carcinoma risk | 2.1 | 49 | Citations (PDF) |
| 39 | Applying core theory and spatial analysis to identify hepatitis C virus infection “core areas” in British Columbia, Canada | 2.1 | 4 | Citations (PDF) |
| 40 | Sustained virological response from interferon-based hepatitis C regimens is associated with reduced risk of extrahepatic manifestations | 3.6 | 33 | Citations (PDF) |
| 41 | What is killing people with hepatitis C virus infection? Analysis of a population-based cohort in Canada | 3.4 | 20 | Citations (PDF) |
| 42 | Hepatitis C virus treatment in people who inject drugs (PWID) in Bangladesh | 3.4 | 9 | Citations (PDF) |
| 43 | Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy | 4.6 | 25 | Citations (PDF) |
| 44 | Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets | 3.4 | 93 | Citations (PDF) |
| 45 | Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study | 2.1 | 22 | Citations (PDF) |
| 46 | Effect of opioid-substitution therapy and mental health counseling on HIV risk among hepatitis C-infected individuals | 2.7 | 7 | Citations (PDF) |
| 47 | Estimating the impact of early hepatitis C virus clearance on hepatocellular carcinoma risk | 2.1 | 9 | Citations (PDF) |
| 48 | Linked data and inclusion health: Harmonised international data linkage to identify determinants of health inequalities | 0.1 | 0 | Citations (PDF) |
| 49 | Differential spatial distribution of hepatitis B virus by ethnicity in British Columbia, Canada: Expanded role of a large administrative cohort | 0.1 | 0 | Citations (PDF) |
| 50 | Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study | 23.6 | 103 | Citations (PDF) |
| 51 | Hepatitis C cross-genotype immunity and implications for vaccine development | 3.5 | 12 | Citations (PDF) |
| 52 | Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants | 2.4 | 65 | Citations (PDF) |
| 53 | Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort | 2.8 | 48 | Citations (PDF) |
| 54 | Towards safe injection practices for prevention of hepatitis C transmission in South Asia: Challenges and progress | 4.8 | 26 | Citations (PDF) |
| 55 | Association of Household and Community Socioeconomic Position and Urbanicity with Underweight and Overweight among Women in Pakistan | 2.4 | 26 | Citations (PDF) |
| 56 | Barriers and Facilitators of Compliance with Universal Precautions at First Level Health Facilities in Northern Rural Pakistan | 0.8 | 3 | Citations (PDF) |
| 57 | Does knowledge about bloodborne pathogens influence the reuse of medical injection syringes among women in Pakistan? | 3.9 | 12 | Citations (PDF) |
| 58 | Health belief model to predict sharps injuries among health care workers at first level care facilities in rural Pakistan | 2.9 | 13 | Citations (PDF) |
| 59 | Disposal of syringes, needles, and lancets used by diabetic patients in Pakistan | 3.9 | 32 | Citations (PDF) |
| 60 | School Absenteeism As an Adjunct Surveillance Indicator: Experience during the Second Wave of the 2009 H1N1 Pandemic in Quebec, Canada | 2.4 | 33 | Citations (PDF) |
| 61 | Maternal and Early Childhood Risk Factors for Overweight and Obesity among Low-Income Predominantly Black Children at Age Five Years: A Prospective Cohort Study | 3.8 | 43 | Citations (PDF) |
| 62 | Association of Socioeconomic Position With Under- and Overnutrition in Pakistan | 1.8 | 12 | Citations (PDF) |
| 63 | Determinants of low birth weight in urban Pakistan | 2.2 | 28 | Citations (PDF) |
| 64 | Health burden of skin lesions at low arsenic exposure through groundwater in Pakistan. Is river the source? | 7.9 | 100 | Citations (PDF) |
| 65 | Status of children's blood lead levels in Pakistan: Implications for research and policy | 2.7 | 41 | Citations (PDF) |
| 66 | Maternal nutritional status during pregnancy and surma use determine cord lead levels in Karachi, Pakistan | 7.9 | 34 | Citations (PDF) |
| 67 | Estimates of intraclass correlation coefficient and design effect for surveys and cluster randomized trials on injection use in Pakistan and developing countries | 2.0 | 16 | Citations (PDF) |
| 68 | Acute health effects of the Tasman Spirit oil spill on residents of Karachi, Pakistan | 3.3 | 63 | Citations (PDF) |
| 69 | From Conflict to Collaboration, Local Political Climate Accelerates ITREOH's Regionalization in South Asia | 1.7 | 2 | Citations (PDF) |
| 70 | Injection use in two districts of Pakistan: implications for disease prevention | 1.2 | 44 | Citations (PDF) |
| 71 | Interventions for improvement in unsafe injection practices in Pakistan | 2.2 | 4 | Citations (PDF) |
| 72 | The Impact of Mask Mandates on Face Mask Use During the COVID-19 Pandemic: Longitudinal Survey Study | 3.0 | 16 | Citations (PDF) |
| 73 | Ethnic Disparities in COVID-19 Vaccine Mistrust and Receipt in British Columbia, Canada: Population Survey | 3.0 | 6 | Citations (PDF) |
